References
- de Duve C., Pressman B.C., Gianetto R., Wattiaux R., Appelmans F. Tissue fractionation studies 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochemical Journal 1955; 60: 604–617
- Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959; 82: 70–77
- Habig W.H., Keen J.H., Jakoby W.B. Glutathione S-transferase in the formation of cyanide from organic thiocyanates and as an organic nitrate reductase. Biochemical and Biophysical Research Communications 1975; 64: 501–506
- Habig W.H., Jakoby W.B. Assays for differentiation of glutathione S-transferases. Methods in Enzymology, W.B. Jakoby. Academic Press. 1981; 77: 398–405
- Kawashima K., Watanabe T., Sokabe H. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and β-adrenoceptor blocking actions, in rabbits. Japanese Journal of Pharmacology 1984; 36: 519–526
- Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Needleman P. Organic nitrate metabolism. Annual Reviews in Pharmacology and Toxicology 1976; 16: 81–93
- Needleman P., Hunter F.E., Jr. The transformation of glyceryl trinitrate and other nitrates by glutathione-organic nitrate reductase. Molecular Pharmacology 1965; 1: 77–86
- Needleman P., Krantz J.C., Jr. The biotransformation of nitroglycerin. Biochemical Pharmacology 1965; 14: 1225–1230
- Sasame H.A., Boyd M.R. Paradoxical effects of cobaltous chloride and salts of other divalent metals on tissue levels of reduced glutathione and microsomal mixed-function oxidase components. Journal of Pharmacology and Experimental Therapeutics 1978; 205: 718–724
- Sedgwick B., Hubscher G. Metabolism of phospholipids IX. Phosphatidate phospho-hydrolase in rat liver. Biochimica et Biophysica Acta 1965; 106: 63–77
- Shechter H., Gruener N., Shuval H.I. A micromethod for the determination of nitrite in blood. Anaiytica Chimica Acta 1972; 60: 93–99
- Yoshimura M., Kojima J., Itoh T., Suzuki J. Pharmacokinetics of nipradilol (K-351), a new hypertensive agent. I. Studies on interspecies variation in laboratory animals. Journal of Pharmacobio-Dynamics 1985; 8: 738–750
- Uchida Y., Nakamura M., Shimizu S., Shirasawa Y., Fujii M. Vasoactive and β-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent. Archives Internationales de Pharmacodynamie et de Therapie 1983; 262: 132–149